Drug Shortages Near an All-Time High, Leading to Rationing

A worrisome scarcity of cancer drugs has heightened concerns about the troubled generic drug industry. Congress and the White House are seeking ways to address widespread supply problems.

U.S. Sues to Block Amgen’s $27.8 Billion Takeover of Horizon Therapeutics

The Federal Trade Commission said the deal would enable Amgen to “entrench” the monopoly positions of two Horizon drugs that lack competition.

Some Pharmacies Are Offering Unauthorized Ozempic Alternatives

Regulators are raising concerns about compounded semaglutide.

A U.S. Experiment on Single-Payer Care Just Ended

The system for one disease, Covid, had similarities to “Medicare for all.”

Esto se sabe sobre Opill, la nueva ‘minipíldora’ anticonceptiva

Los asesores de la FDA afirman que los beneficios superan sus riesgos. La agencia decidirá si en pocos meses el anticonceptivo podrá venderse sin receta en Estados Unidos.

What to Know About the New Treatment for Hot Flashes

Veozah, a nonhormonal drug, is effective against a signature symptom of menopause.

FDA Approves New Drug to Treat Hot Flashes

It is the first nonhormonal treatment for the menopause symptom.

Public Health Lessons Learned From the Coronavirus Pandemic

The United States’ struggle to respond to the virus has highlighted the importance of communicating with the public, sharing data and stockpiling vital supplies.

Addiction Treatment Medicine Is Vastly Underprescribed, Especially by Race, Study Finds

Black patients with opioid use disorder were far less likely to fill prescriptions for the most effective addiction treatments than white patients. But strikingly few patients of all races got the medicine.